The FDA has approved a subcutaneous dose for initiation of lecanemab treatment in adults with Alzheimer’s disease, according ...

Biopharma companies must weigh the operational complexity of continuous bioprocess against its potential productivity gains.

Once peer review is completed and the editor is satisfied that any concerns raised by the reviewers have been suitably addressed, the paper is accepted ‘in principle’ (AIP). The editor will send ...